Multicenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiography

European Radiology

Volumn 13, Issue 7, 2003, Pages 1620-1627

  Leiner, Tim ^a,f   Ho, Kai Yiu J A M ^a,g   Ho, Vincent B ^b   Bongartz, Georg ^c   Mali, Willem P T M ^d   Rasch, Wenche ^e   van Engelshoven, Jos M A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Amersham Health   (Norway)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angiography; Arteries; Comparative studies; Contrast media; Extremities; Magnetic resonance; Toxicity; Vascular studies

Indexed keywords

GADOLINIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FATIGUE; FEMALE; FEMORAL ARTERY; FLU LIKE SYNDROME; GAIT DISORDER; HEMATURIA; HEMODYNAMICS; HUMAN; HYPESTHESIA; ILIAC ARTERY; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; POPLITEAL ARTERY; PRIORITY JOURNAL; RHINITIS; SENSITIVITY AND SPECIFICITY; STEADY STATE; VERTIGO;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; OXIDES; PERIPHERAL VASCULAR DISEASES; SAFETY; SENSITIVITY AND SPECIFICITY;

EID: 0037591835     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1791-6     Document Type: Article

References (21)

1. Ho KYJAM, Leiner T, de Haan MW, Kessels AGH, Kitslaar PJEHM, van Engelshoven JMA (1998) Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 206:683-692
2. Meaney JFM, Ridgway JP, Chakraverty S et al. (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211:59-67
3. Ho VB, Choyke PL, Foo TK et al. (1999) Automated bolus chase peripheral MR angiography: initial practical experiences and future directions of this work-in-progress. J Magn Reson Imaging 10:376-388
4. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF (2000) Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. Am J Roentgenol 174:1127-1135
5. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477-484
6. Kroft LJ, de Roos A (1999) Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 10:395-403
7. Stillman AE, Wilke N, Li D, Haacke EM, McLaughlan S (1996) Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 20:51-55
8. Anzai Y, Prince MR, Chenevert TL et al. (1997) MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 7:209-214
9. Taylor AM, Panting JR, Keegan J et al. (1999) Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 9:220-227
10. Weishaupt D, Ruehm SG, Binkert CA et al. (2000) Equilibrium-phase MR angiography of the aortoiliac and renal arteries using a blood pool contrast agent. Am J Roentgenol 175:189-195
11. Kellar KE, Fujii DK, Gunther WH et al. (2000) NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography. J Magn Reson Imaging 11:488-494
12. Panting JR, Taylor AM, Gatehouse PD et al. (1999) First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection. J Magn Reson Imaging 10:404-410
13. International Conference on Harmonisation (ICH) ICH harmonised tripartite guideline for good clinical practice. Brookwood Medical Publications, Surrey, 1996
14. Baker E, Morgan EH (1994) Iron transport. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. Saunders, London
15. Wildermuth S, Dubno R, Romanowski J et al. (1998) Open-label, phase 1 trial of a new blood pool contrast agent (NC100150) in 12 healthy volunteers: safety and vascular imaging characteristics (abstr). In: Proc Sixth Meeting of the International Society for Magnetic Resonance in Medicine. International Society for Magnetic Resonance in Medicine, Berkeley, Calif., p 48
16. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM (2000) Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 217:105-114
17. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM (2001) Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. J Am Med Assoc 285:1338-1345
18. Grist TM, Korosec FR, Peters DC et al. (1998) Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 207:539-544
19. Ho KYJAM, Leiner T, van Engelshoven JMA (1999) First-pass bloodpool-enhanced MRA of the peripheral arteries as an aid to separation of arteries from veins in high-resolution bloodpool-enhanced MRA. Radiology 213(P):481
20. Foo TKF, Ho VB, Hood MN, Hess SL, Choyke PL (2001) Preferential arterial imaging using gated thick-slice gadolinium-enhanced phase contrast acquisition in peripheral MRA. J Magn Reson Imaging 13:714-721
21. Tizon X, Smedby O (2002) Segmentation with grey-scale connectedness can separate arteries and veins in MRA. J Magn Reson Imaging 15:438-445